{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T04:14:52Z","timestamp":1793592892592,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The General Program of the National Natural Science Foundation of China","award":["81671177"],"award-info":[{"award-number":["81671177"]}]},{"name":"Natural Science Foundation of Jilin Province Science and Technology Development Plan Project","award":["20190201043JC"],"award-info":[{"award-number":["20190201043JC"]}]},{"name":"The Technology Innovation Program of Jilin Provincial Health and Family Planning Commission of China","award":["2016J040"],"award-info":[{"award-number":["2016J040"]}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","award":["2015-03005"],"award-info":[{"award-number":["2015-03005"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transitional B cells (TrB cells) represent a crucial link between immature B cells in the bone marrow and mature peripheral B cells. Although TrB cells represent one of the regulatory B cell subpopulations in healthy individuals, the frequency of CD24<jats:sup>hi<\/jats:sup>CD38<jats:sup>hi<\/jats:sup> TrB cells in circulation may be altered in individuals with autoimmune diseases, such as multiple sclerosis, neuromyelitisoptica spectrum disorders, systemic lupus erythematosus, Sj\u00f6gren\u2019s syndrome, rheumatoid arthritis, systemic sclerosis, and juvenile dermatomyositis. Although TrB cells play regulatory roles under inflammatory conditions, consequences of their functional impairment vary across autoimmune diseases. Since the origin, development, and function of TrB cells, especially in humans, remain unclear and controversial, this review aimed to discuss the characteristics of TrB cells at steady state and explore their role in various immune diseases, including autoimmune rheumatic diseases and neuroimmunological diseases.<\/jats:p>","DOI":"10.1186\/s12967-020-02289-w","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:02:47Z","timestamp":1584450167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":104,"title":["Transitional B cells involved in autoimmunity and their impact on neuroimmunological diseases"],"prefix":"10.1186","volume":"18","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3419","authenticated-orcid":false,"given":"Tao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"1","key":"2289_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41581-018-0074-7","volume":"15","author":"K Oleinika","year":"2019","unstructured":"Oleinika K, Mauri C, Salama AD. Effector and regulatory B cells in immune-mediated kidney disease. Nat Rev Nephrol. 2019;15(1):11\u201326.","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"2289_CR2","first-page":"156","volume":"35","author":"H Rincon-Arevalo","year":"2016","unstructured":"Rincon-Arevalo H, Sanchez-Parra CC, Castano D, et al. Regulatory B cells and mechanisms. Int Rev Immunol. 2016;35(2):156\u201376.","journal-title":"Int Rev Immunol"},{"issue":"9","key":"2289_CR3","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1084\/jem.20122465","volume":"210","author":"A Vossenkamper","year":"2013","unstructured":"Vossenkamper A, Blair PA, Safinia N, et al. A role for gut-associated lymphoid tissue in shaping the human B cell repertoire. J Exp Med. 2013;210(9):1665\u201374.","journal-title":"J Exp Med"},{"issue":"1","key":"2289_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1084\/jem.190.1.75","volume":"190","author":"F Loder","year":"1999","unstructured":"Loder F, Mutschler B, Ray RJ, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med. 1999;190(1):75\u201389.","journal-title":"J Exp Med"},{"issue":"11","key":"2289_CR5","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.1182\/blood-2004-11-4284","volume":"105","author":"GP Sims","year":"2005","unstructured":"Sims GP, Ettinger R, Shirota Y, et al. Identification and characterization of circulating human transitional B cells. Blood. 2005;105(11):4390\u20138.","journal-title":"Blood"},{"issue":"1","key":"2289_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clim.2007.11.013","volume":"127","author":"A Marie-Cardine","year":"2008","unstructured":"Marie-Cardine A, Divay F, Dutot I, et al. Transitional B cells in humans: characterization and insight from B lymphocyte reconstitution after hematopoietic stem cell transplantation. Clin Immunol. 2008;127(1):14\u201325.","journal-title":"Clin Immunol"},{"issue":"1","key":"2289_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/cei.12149","volume":"174","author":"S Agrawal","year":"2013","unstructured":"Agrawal S, Smith SA, Tangye SG, et al. Transitional B cell subsets in human bone marrow. Clin Exp Immunol. 2013;174(1):53\u20139.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"2289_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","volume":"137","author":"Q Simon","year":"2016","unstructured":"Simon Q, Pers JO, Cornec D, et al. In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles. J Allergy Clin Immunol. 2016;137(5):1577\u20131584.e10.","journal-title":"J Allergy Clin Immunol"},{"key":"2289_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","volume":"197","author":"R Carsetti","year":"2004","unstructured":"Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179\u201391.","journal-title":"Immunol Rev"},{"issue":"3","key":"2289_CR10","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1084\/jem.20060964","volume":"204","author":"MC van Zelm","year":"2007","unstructured":"van Zelm MC, Szczepanski T, van der Burg M, et al. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204(3):645\u201355.","journal-title":"J Exp Med"},{"issue":"1","key":"2289_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F, et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129\u201340.","journal-title":"Immunity"},{"issue":"2","key":"2289_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s12016-017-8608-5","volume":"53","author":"G Carvajal Alegria","year":"2017","unstructured":"Carvajal Alegria G, Gazeau P, Hillion S, et al. Could lymphocyte profiling be useful to diagnose systemic autoimmune diseases? Clin Rev Allergy Immunol. 2017;53(2):219\u201336.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"2289_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/art.40390","volume":"70","author":"TE Taher","year":"2018","unstructured":"Taher TE, Ong VH, Bystrom J, et al. Association of defective regulation of autoreactive interleukin-6-producing transitional B lymphocytes with disease in patients with systemic sclerosis. Arthr Rheumatol. 2018;70(3):450\u201361.","journal-title":"Arthr Rheumatol"},{"key":"2289_CR14","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3389\/fimmu.2018.01372","volume":"9","author":"CJM Piper","year":"2018","unstructured":"Piper CJM, Wilkinson MGL, Deakin CT, et al. CD19(+)CD24(hi)CD38(hi) B cells are expanded in juvenile dermatomyositis and exhibit a pro-inflammatory phenotype after activation through toll-like receptor 7 and interferon-alpha. Front Immunol. 2018;9:1372.","journal-title":"Front Immunol"},{"issue":"1","key":"2289_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clim.2010.11.004","volume":"139","author":"C Lee-Chang","year":"2011","unstructured":"Lee-Chang C, Top I, Zephir H, et al. Primed status of transitional B cells associated with their presence in the cerebrospinal fluid in early phases of multiple sclerosis. Clin Immunol. 2011;139(1):12\u201320.","journal-title":"Clin Immunol"},{"issue":"3","key":"2289_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/1352458512454771","volume":"19","author":"C Quan","year":"2013","unstructured":"Quan C, Yu H, Qiao J, et al. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis. Mult Scler. 2013;19(3):289\u201398.","journal-title":"Mult Scler"},{"issue":"13","key":"2289_CR17","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1097\/QAD.0b013e32833c3298","volume":"24","author":"A Cagigi","year":"2010","unstructured":"Cagigi A, Palma P, Nilsson A, et al. The impact of active HIV-1 replication on the physiological age-related decline of immature-transitional B-cells in HIV-1 infected children. AIDS. 2010;24(13):2075\u201380.","journal-title":"AIDS"},{"issue":"5","key":"2289_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/hep.25821","volume":"56","author":"LE Holz","year":"2012","unstructured":"Holz LE, Yoon JC, Raghuraman S, et al. B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through naive B cell apoptosis. Hepatology. 2012;56(5):1602\u201310.","journal-title":"Hepatology"},{"issue":"6","key":"2289_CR19","doi-asserted-by":"publisher","first-page":"e1002089","DOI":"10.1371\/journal.ppat.1002089","volume":"7","author":"V Bockstal","year":"2011","unstructured":"Bockstal V, Guirnalda P, Caljon G, et al. T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis. PLoS Pathog. 2011;7(6):e1002089.","journal-title":"PLoS Pathog"},{"issue":"3","key":"2289_CR20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1074-7613(00)80029-1","volume":"10","author":"PC Sandel","year":"1999","unstructured":"Sandel PC, Monroe JG. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity. 1999;10(3):289\u201399.","journal-title":"Immunity"},{"key":"2289_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.0105-2896.2004.0108.x","volume":"197","author":"D Allman","year":"2004","unstructured":"Allman D, Srivastava B, Lindsley RC. Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells. Immunol Rev. 2004;197:147\u201360.","journal-title":"Immunol Rev"},{"key":"2289_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.immunol.19.1.595","volume":"19","author":"RR Hardy","year":"2001","unstructured":"Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595\u2013621.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"2289_CR23","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.4049\/jimmunol.168.5.2101","volume":"168","author":"TT Su","year":"2002","unstructured":"Su TT, Rawlings DJ. Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol. 2002;168(5):2101\u201310.","journal-title":"J Immunol"},{"issue":"8","key":"2289_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol. 2005;5(8):606\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2289_CR25","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1084\/jem.20091489","volume":"207","author":"RB Henderson","year":"2010","unstructured":"Henderson RB, Grys K, Vehlow A, et al. A novel Rac-dependent checkpoint in B cell development controls entry into the splenic white pulp and cell survival. J Exp Med. 2010;207(4):837\u201353.","journal-title":"J Exp Med"},{"issue":"50","key":"2289_CR26","doi-asserted-by":"publisher","first-page":"48009","DOI":"10.1074\/jbc.M200305200","volume":"277","author":"JB Petro","year":"2002","unstructured":"Petro JB, Gerstein RM, Lowe J, et al. Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem. 2002;277(50):48009\u201319.","journal-title":"J Biol Chem"},{"key":"2289_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.12815","volume":"292","author":"JA Hamilton","year":"2019","unstructured":"Hamilton JA, Hsu HC, Mountz JD. Autoreactive B cells in SLE, villains or innocent bystanders? Immunol Rev. 2019;292:120\u201338.","journal-title":"Immunol Rev"},{"issue":"6","key":"2289_CR28","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1471-4906(03)00119-4","volume":"24","author":"JB Chung","year":"2003","unstructured":"Chung JB, Silverman M, Monroe JG. Transitional B cells: step by step towards immune competence. Trends Immunol. 2003;24(6):342\u20138.","journal-title":"Trends Immunol"},{"issue":"10","key":"2289_CR29","doi-asserted-by":"publisher","first-page":"4610","DOI":"10.4049\/jimmunol.1300692","volume":"192","author":"A Benitez","year":"2014","unstructured":"Benitez A, Weldon AJ, Tatosyan L, et al. Differences in mouse and human nonmemory B cell pools. J Immunol. 2014;192(10):4610\u20139.","journal-title":"J Immunol"},{"issue":"12","key":"2289_CR30","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.4049\/jimmunol.167.12.6834","volume":"167","author":"D Allman","year":"2001","unstructured":"Allman D, Lindsley RC, Demuth W, et al. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol. 2001;167(12):6834\u201340.","journal-title":"J Immunol"},{"issue":"3","key":"2289_CR31","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/ni893","volume":"4","author":"K Saijo","year":"2003","unstructured":"Saijo K, Schmedt C, Su IH, et al. Essential role of Src-family protein tyrosine kinases in NF-\u03baB activation during B cell development. Nat Immunol. 2003;4(3):274\u20139.","journal-title":"Nat Immunol"},{"issue":"12","key":"2289_CR32","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2(12):945\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2289_CR33","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4049\/jimmunol.1403171","volume":"195","author":"S Huttl","year":"2015","unstructured":"Huttl S, Klasener K, Schweizer M, et al. Processing of CD74 by the intramembrane protease SPPL2a is critical for B cell receptor signaling in transitional B cells. J Immunol. 2015;195(4):1548\u201363.","journal-title":"J Immunol"},{"issue":"4","key":"2289_CR34","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.4049\/jimmunol.173.4.2245","volume":"173","author":"Y Sasaki","year":"2004","unstructured":"Sasaki Y, Casola S, Kutok JL, et al. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol. 2004;173(4):2245\u201352.","journal-title":"J Immunol"},{"issue":"2","key":"2289_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","volume":"15","author":"JA Gross","year":"2001","unstructured":"Gross JA, Dillon SR, Mudri S, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15(2):289\u2013302.","journal-title":"Immunity"},{"issue":"8","key":"2289_CR36","doi-asserted-by":"publisher","first-page":"4570","DOI":"10.4049\/jimmunol.1001708","volume":"185","author":"SL Rowland","year":"2010","unstructured":"Rowland SL, Leahy KF, Halverson R, et al. BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling. J Immunol. 2010;185(8):4570\u201381.","journal-title":"J Immunol"},{"issue":"1","key":"2289_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/eji.201141957","volume":"42","author":"R Tussiwand","year":"2012","unstructured":"Tussiwand R, Rauch M, Fluck LA, et al. BAFF-R expression correlates with positive selection of immature B cells. Eur J Immunol. 2012;42(1):206\u201316.","journal-title":"Eur J Immunol"},{"issue":"6","key":"2289_CR38","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1084\/jem.181.6.2129","volume":"181","author":"R Carsetti","year":"1995","unstructured":"Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med. 1995;181(6):2129\u201340.","journal-title":"J Exp Med"},{"issue":"11","key":"2289_CR39","doi-asserted-by":"publisher","first-page":"7544","DOI":"10.4049\/jimmunol.179.11.7544","volume":"179","author":"H Wang","year":"2007","unstructured":"Wang H, Feng J, Qi CF, et al. Transitional B cells lose their ability to receptor edit but retain their potential for positive and negative selection. J Immunol. 2007;179(11):7544\u201352.","journal-title":"J Immunol"},{"issue":"12","key":"2289_CR40","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.4049\/jimmunol.171.12.6381","volume":"171","author":"H Wang","year":"2003","unstructured":"Wang H, Clarke SH. Evidence for a ligand-mediated positive selection signal in differentiation to a mature B cell. J Immunol. 2003;171(12):6381\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"2289_CR41","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.coi.2008.03.015","volume":"20","author":"JE Stadanlick","year":"2008","unstructured":"Stadanlick JE, Cancro MP. BAFF and the plasticity of peripheral B cell tolerance. Curr Opin Immunol. 2008;20(2):158\u201361.","journal-title":"Curr Opin Immunol"},{"issue":"7414","key":"2289_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nature11311","volume":"489","author":"J Zikherman","year":"2012","unstructured":"Zikherman J, Parameswaran R, Weiss A. Endogenous antigen tunes the responsiveness of naive B cells but not T cells. Nature. 2012;489(7414):160\u20134.","journal-title":"Nature"},{"issue":"1","key":"2289_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1084\/jem.20071088","volume":"205","author":"A Meyer-Bahlburg","year":"2008","unstructured":"Meyer-Bahlburg A, Andrews SF, Yu KO, et al. Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med. 2008;205(1):155\u201368.","journal-title":"J Exp Med"},{"issue":"10","key":"2289_CR44","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20150585","volume":"212","author":"NS Kolhatkar","year":"2015","unstructured":"Kolhatkar NS, Brahmandam A, Thouvenel CD, et al. Altered BCR and TLR signals promote enhanced positive selection of autoreactive transitional B cells in Wiskott-Aldrich syndrome. J Exp Med. 2015;212(10):1663\u201377.","journal-title":"J Exp Med"},{"issue":"5","key":"2289_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00005-011-0135-0","volume":"59","author":"A Vossenkamper","year":"2011","unstructured":"Vossenkamper A, Spencer J. Transitional B cells: how well are the checkpoints for specificity understood? Arch Immunol Ther Exp (Warsz). 2011;59(5):379\u201384.","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"4","key":"2289_CR46","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","volume":"131","author":"K Pieper","year":"2013","unstructured":"Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131(4):959\u201371.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2289_CR47","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1586\/eci.10.55","volume":"6","author":"S Suryani","year":"2010","unstructured":"Suryani S, Tangye SG. Therapeutic implications of advances in our understanding of transitional B-cell development in humans. Expert Rev Clin Immunol. 2010;6(5):765\u201375.","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"2289_CR48","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1182\/blood-2009-07-234799","volume":"115","author":"S Suryani","year":"2010","unstructured":"Suryani S, Fulcher DA, Santner-Nanan B, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 2010;115(3):519\u201329.","journal-title":"Blood"},{"issue":"5638","key":"2289_CR49","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1126\/science.1086907","volume":"301","author":"H Wardemann","year":"2003","unstructured":"Wardemann H, Yurasov S, Schaefer A, et al. Predominant autoantibody production by early human B cell precursors. Science. 2003;301(5638):1374\u20137.","journal-title":"Science"},{"issue":"10","key":"2289_CR50","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.4049\/jimmunol.0801859","volume":"182","author":"A Palanichamy","year":"2009","unstructured":"Palanichamy A, Barnard J, Zheng B, et al. Novel human transitional B cell populations revealed by B cell depletion therapy. J Immunol. 2009;182(10):5982\u201393.","journal-title":"J Immunol"},{"issue":"10","key":"2289_CR51","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jnr.24023","volume":"95","author":"Y Cheng","year":"2017","unstructured":"Cheng Y, Sun L, Xie Z, et al. Diversity of immune cell types in multiple sclerosis and its animal model: pathological and therapeutic implications. J Neurosci Res. 2017;95(10):1973\u201383.","journal-title":"J Neurosci Res"},{"issue":"7","key":"2289_CR52","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s10072-017-2932-7","volume":"38","author":"J Han","year":"2017","unstructured":"Han J, Sun L, Wang Z, et al. Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders. Neurol Sci. 2017;38(7):1205\u201312.","journal-title":"Neurol Sci"},{"issue":"8","key":"2289_CR53","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jnr.23749","volume":"94","author":"J Han","year":"2016","unstructured":"Han J, Sun L, Fan X, et al. Role of regulatory b cells in neuroimmunologic disorders. J Neurosci Res. 2016;94(8):693\u2013701.","journal-title":"J Neurosci Res"},{"issue":"2","key":"2289_CR54","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530\u201341.","journal-title":"Blood"},{"issue":"6","key":"2289_CR55","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","volume":"41","author":"M Matsumoto","year":"2014","unstructured":"Matsumoto M, Baba A, Yokota T, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41(6):1040\u201351.","journal-title":"Immunity"},{"issue":"8","key":"2289_CR56","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4049\/jimmunol.1900488","volume":"203","author":"MM Hasan","year":"2019","unstructured":"Hasan MM, Thompson-Snipes L, Klintmalm G, et al. CD24(hi)CD38(hi) and CD24(hi)CD27(+) human regulatory B cells display common and distinct functional characteristics. J Immunol. 2019;203(8):2110\u201320.","journal-title":"J Immunol"},{"issue":"2","key":"2289_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/intimm\/14.2.157","volume":"14","author":"JB Chung","year":"2002","unstructured":"Chung JB, Sater RA, Fields ML, et al. CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals. Int Immunol. 2002;14(2):157\u201366.","journal-title":"Int Immunol"},{"issue":"3","key":"2289_CR58","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.4049\/jimmunol.176.3.1506","volume":"176","author":"AK Cuss","year":"2006","unstructured":"Cuss AK, Avery DT, Cannons JL, et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol. 2006;176(3):1506\u201316.","journal-title":"J Immunol"},{"issue":"12","key":"2289_CR59","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","volume":"178","author":"JG Evans","year":"2007","unstructured":"Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007;178(12):7868\u201378.","journal-title":"J Immunol"},{"issue":"10","key":"2289_CR60","first-page":"3420","volume":"118","author":"T Matsushita","year":"2008","unstructured":"Matsushita T, Yanaba K, Bouaziz JD, et al. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest. 2008;118(10):3420\u201330.","journal-title":"J Clin Invest"},{"issue":"10","key":"2289_CR61","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","volume":"186","author":"NA Carter","year":"2011","unstructured":"Carter NA, Vasconcellos R, Rosser EC, et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells. J Immunol. 2011;186(10):5569\u201379.","journal-title":"J Immunol"},{"issue":"1","key":"2289_CR62","doi-asserted-by":"publisher","first-page":"R32","DOI":"10.1186\/ar3736","volume":"14","author":"NA Carter","year":"2012","unstructured":"Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther. 2012;14(1):R32.","journal-title":"Arthritis Res Ther"},{"key":"2289_CR63","doi-asserted-by":"publisher","first-page":"20044","DOI":"10.1038\/srep20044","volume":"6","author":"E Nova-lamperti","year":"2016","unstructured":"Nova-lamperti E, Fanelli G, Becker PD, et al. IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+ T-cell responses. Sci Rep. 2016;6:20044.","journal-title":"Sci Rep"},{"issue":"173","key":"2289_CR64","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-borja","year":"2013","unstructured":"Flores-borja F, Bosma A, Ng D, et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23.","journal-title":"Sci Transl Med"},{"issue":"3","key":"2289_CR65","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","volume":"36","author":"A Bosma","year":"2012","unstructured":"Bosma A, Abdel-Gadir A, Isenberg DA, et al. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity. 2012;36(3):477\u201390.","journal-title":"Immunity"},{"key":"2289_CR66","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/ncomms6997","volume":"6","author":"AR Khan","year":"2015","unstructured":"Khan AR, Hams E, Floudas A, et al. PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun. 2015;6:5997.","journal-title":"Nat Commun"},{"issue":"1","key":"2289_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.kint.2016.10.028","volume":"91","author":"H Burton","year":"2017","unstructured":"Burton H, Dorling A. Transitional B cell subsets-a convincing predictive biomarker for allograft loss? Kidney Int. 2017;91(1):18\u201320.","journal-title":"Kidney Int"},{"issue":"4","key":"2289_CR68","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41423-018-0010-6","volume":"16","author":"M Liu","year":"2019","unstructured":"Liu M, Guo Q, Wu C, et al. Type I interferons promote the survival and proinflammatory properties of transitional B cells in systemic lupus erythematosus patients. Cell Mol Immunol. 2019;16(4):367\u201379.","journal-title":"Cell Mol Immunol"},{"issue":"7152","key":"2289_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature05970","volume":"448","author":"T Korn","year":"2007","unstructured":"Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature. 2007;448(7152):484\u20137.","journal-title":"Nature"},{"issue":"1","key":"2289_CR70","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/imr.12374","volume":"269","author":"AC Lino","year":"2016","unstructured":"Lino AC, Dorner T, Bar-Or A, et al. Cytokine-producing B cells: a translational view on their roles in human and mouse autoimmune diseases. Immunol Rev. 2016;269(1):130\u201344.","journal-title":"Immunol Rev"},{"issue":"7","key":"2289_CR71","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nri2572","volume":"9","author":"F Mackay","year":"2009","unstructured":"Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. 2009;9(7):491\u2013502.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"2289_CR72","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","volume":"20","author":"R Lesley","year":"2004","unstructured":"Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20(4):441\u201353.","journal-title":"Immunity"},{"key":"2289_CR73","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.0105-2896.2004.0099.x","volume":"197","author":"MP Cancro","year":"2004","unstructured":"Cancro MP. Peripheral B-cell maturation: the intersection of selection and homeostasis. Immunol Rev. 2004;197:89\u2013101.","journal-title":"Immunol Rev"},{"issue":"9","key":"2289_CR74","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","volume":"9","author":"MM Varin","year":"2010","unstructured":"Varin MM, le Pottier L, Youinou P, et al. B-cell tolerance breakdown in Sjogren\u2019s syndrome: focus on BAFF. Autoimmun Rev. 2010;9(9):604\u20138.","journal-title":"Autoimmun Rev"},{"issue":"5537","key":"2289_CR75","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1126\/science.1061964","volume":"293","author":"B Schiemann","year":"2001","unstructured":"Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 2001;293(5537):2111\u20134.","journal-title":"Science"},{"key":"2289_CR76","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3389\/fimmu.2018.01636","volume":"9","author":"M Tarique","year":"2018","unstructured":"Tarique M, Naz H, Kurra SV, et al. Interleukin-10 producing regulatory B cells transformed CD4(+)CD25(\u2212) into tregs and enhanced regulatory T cells function in human leprosy. Front Immunol. 2018;9:1636.","journal-title":"Front Immunol"},{"issue":"12","key":"2289_CR77","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.4049\/jimmunol.1300749","volume":"192","author":"A Granato","year":"2014","unstructured":"Granato A, Hayashi EA, Baptista BJ, et al. IL-4 regulates Bim expression and promotes B cell maturation in synergy with BAFF conferring resistance to cell death at negative selection checkpoints. J Immunol. 2014;192(12):5761\u201375.","journal-title":"J Immunol"},{"key":"2289_CR78","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","volume":"17","author":"K Nelms","year":"1999","unstructured":"Nelms K, Keegan AD, Zamorano J, et al. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701\u201338.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"2289_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1042\/CS20110340","volume":"122","author":"M Mihara","year":"2012","unstructured":"Mihara M, Hashizume M, Yoshida H, et al. IL-6\/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond). 2012;122(4):143\u201359.","journal-title":"Clin Sci (Lond)"},{"issue":"5","key":"2289_CR80","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16(5):448\u201357.","journal-title":"Nat Immunol"},{"issue":"7090","key":"2289_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature04753","volume":"441","author":"E Bettelli","year":"2006","unstructured":"Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235\u20138.","journal-title":"Nature"},{"issue":"9","key":"2289_CR82","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/ni1496","volume":"8","author":"EV Acosta-Rodriguez","year":"2007","unstructured":"Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. Interleukins 1\u03b2 and 6 but not transforming growth factor-\u03b2 are essential for the differentiation of interleukin 17\u2013producing human T helper cells. Nat Immunol. 2007;8(9):942\u20139.","journal-title":"Nat Immunol"},{"issue":"26","key":"2289_CR83","doi-asserted-by":"publisher","first-page":"9041","DOI":"10.1073\/pnas.0802218105","volume":"105","author":"S Serada","year":"2008","unstructured":"Serada S, Fujimoto M, Mihara M, et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA. 2008;105(26):9041\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2289_CR84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","volume":"141","author":"JL Karnell","year":"2018","unstructured":"Karnell JL, Rieder SA, Ettinger R, et al. Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev. 2018;141:92\u2013103.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3\u20134","key":"2289_CR85","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jaut.2011.01.005","volume":"36","author":"S Lemoine","year":"2011","unstructured":"Lemoine S, Morva A, Youinou P, et al. Human T cells induce their own regulation through activation of B cells. J Autoimmun. 2011;36(3\u20134):228\u201338.","journal-title":"J Autoimmun"},{"issue":"10","key":"2289_CR86","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944\u201350.","journal-title":"Nat Immunol"},{"issue":"4","key":"2289_CR87","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.immuni.2004.09.001","volume":"21","author":"Y Qian","year":"2004","unstructured":"Qian Y, Qin J, Cui G, et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity. 2004;21(4):575\u201387.","journal-title":"Immunity"},{"issue":"8","key":"2289_CR88","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/eji.200738113","volume":"38","author":"Y Qian","year":"2008","unstructured":"Qian Y, Giltiay N, Xiao J, et al. Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren\u2019s syndrome. Eur J Immunol. 2008;38(8):2219\u201328.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2289_CR89","doi-asserted-by":"publisher","first-page":"99","DOI":"10.4049\/jimmunol.0903312","volume":"185","author":"NV Giltiay","year":"2010","unstructured":"Giltiay NV, Lu Y, Allman D, et al. The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation. J Immunol. 2010;185(1):99\u2013109.","journal-title":"J Immunol"},{"issue":"3","key":"2289_CR90","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1189\/jlb.1108704","volume":"87","author":"M Nasirikenari","year":"2010","unstructured":"Nasirikenari M, Chandrasekaran EV, Matta KL, et al. Altered eosinophil profile in mice with ST6Gal-1 deficiency: an additional role for ST6Gal-1 generated by the P1 promoter in regulating allergic inflammation. J Leukoc Biol. 2010;87(3):457\u201366.","journal-title":"J Leukoc Biol"},{"issue":"10","key":"2289_CR91","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1182\/blood-2006-04-014779","volume":"108","author":"M Nasirikenari","year":"2006","unstructured":"Nasirikenari M, Segal BH, Ostberg JR, et al. Altered granulopoietic profile and exaggerated acute neutrophilic inflammation in mice with targeted deficiency in the sialyltransferase ST6Gal I. Blood. 2006;108(10):3397\u2013405.","journal-title":"Blood"},{"issue":"2","key":"2289_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1189\/jlb.3A1216-538RR","volume":"102","author":"CWL Dougher","year":"2017","unstructured":"Dougher CWL, Buffone A Jr, Nemeth MJ, et al. The blood-borne sialyltransferase ST6Gal-1 is a negative systemic regulator of granulopoiesis. J Leukoc Biol. 2017;102(2):507\u201316.","journal-title":"J Leukoc Biol"},{"key":"2289_CR93","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3389\/fimmu.2018.02150","volume":"9","author":"EE Irons","year":"2018","unstructured":"Irons EE, Lau JTY. Systemic ST6Gal-1 is a pro-survival factor for murine transitional B cells. Front Immunol. 2018;9:2150.","journal-title":"Front Immunol"},{"issue":"8","key":"2289_CR94","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1073\/pnas.95.8.4504","volume":"95","author":"T Hennet","year":"1998","unstructured":"Hennet T, Chui D, Paulson JC, et al. Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad Sci USA. 1998;95(8):4504\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2289_CR95","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/ni1004-1008","volume":"5","author":"JD Marth","year":"2004","unstructured":"Marth JD. Unmasking connections in transmembrane immune signaling. Nat Immunol. 2004;5(10):1008\u201310.","journal-title":"Nat Immunol"},{"key":"2289_CR96","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jaut.2019.05.002","volume":"102","author":"Y Dieudonne","year":"2019","unstructured":"Dieudonne Y, Gies V, Guffroy A, et al. Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN. J Autoimmun. 2019;102:150\u20138.","journal-title":"J Autoimmun"},{"issue":"5","key":"2289_CR97","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1136\/annrheumdis-2013-204343","volume":"74","author":"AJ Clarke","year":"2015","unstructured":"Clarke AJ, Ellinghaus U, Cortini A, et al. Autophagy is activated in systemic lupus erythematosus and required for plasmablast development. Ann Rheum Dis. 2015;74(5):912\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"2289_CR98","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1084\/jem.20111675","volume":"209","author":"TA Barr","year":"2012","unstructured":"Barr TA, Shen P, Brown S, et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med. 2012;209(5):1001\u201310.","journal-title":"J Exp Med"},{"issue":"7","key":"2289_CR99","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos J, Saji E, Troscher AR, et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141(7):2066\u201382.","journal-title":"Brain"},{"issue":"10","key":"2289_CR100","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awy239","volume":"141","author":"D Baker","year":"2018","unstructured":"Baker D, Pryce G, Amor S, et al. Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis. Brain. 2018;141(10):2834\u201347.","journal-title":"Brain"},{"issue":"7","key":"2289_CR101","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.autrev.2016.03.006","volume":"15","author":"R Milo","year":"2016","unstructured":"Milo R. Therapeutic strategies targeting B-cells in multiple sclerosis. Autoimmun Rev. 2016;15(7):714\u20138.","journal-title":"Autoimmun Rev"},{"key":"2289_CR102","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.autrev.2019.05.003","volume":"18","author":"E D\u2019amico","year":"2019","unstructured":"D\u2019amico E, Zanghi A, Gastaldi M, et al. Placing CD20-targeted B cell depletion in multiple sclerosis therapeutic scenario: present and future perspectives. Autoimmun Rev. 2019;18:665\u201372.","journal-title":"Autoimmun Rev"},{"issue":"4","key":"2289_CR103","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","volume":"97","author":"C Baecher-Allan","year":"2018","unstructured":"Baecher-Allan C, Kaskow BJ, Weiner HL. Multiple sclerosis: mechanisms and Immunotherapy. Neuron. 2018;97(4):742\u201368.","journal-title":"Neuron"},{"issue":"1","key":"2289_CR104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cell.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, et al. Memory B cells activate brain-homing, autoreactive CD4(+) T cells in multiple sclerosis. Cell. 2018;175(1):85\u2013100.e23.","journal-title":"Cell"},{"issue":"6","key":"2289_CR105","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.coi.2011.09.003","volume":"23","author":"HC von Budingen","year":"2011","unstructured":"von Budingen HC, Bar-Or A, Zamvil SS. B cells in multiple sclerosis: connecting the dots. Curr Opin Immunol. 2011;23(6):713\u201320.","journal-title":"Curr Opin Immunol"},{"issue":"39","key":"2289_CR106","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1073\/pnas.1810470115","volume":"115","author":"D Hausler","year":"2018","unstructured":"Hausler D, Hausser-Kinzel S, Feldmann L, et al. Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease. Proc Natl Acad Sci USA. 2018;115(39):9773\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2289_CR107","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-016-0615-8","volume":"39","author":"A Biragyn","year":"2017","unstructured":"Biragyn A, Aliseychik M, Rogaev E. Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol. 2017;39(3):283\u201394.","journal-title":"Semin Immunopathol"},{"issue":"7","key":"2289_CR108","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","volume":"19","author":"R Li","year":"2018","unstructured":"Li R, Patterson KR, Bar-Or A. Reassessing B cell contributions in multiple sclerosis. Nat Immunol. 2018;19(7):696\u2013707.","journal-title":"Nat Immunol"},{"issue":"4","key":"2289_CR109","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.4049\/jimmunol.1001307","volume":"185","author":"T Matsushita","year":"2010","unstructured":"Matsushita T, Horikawa M, Iwata Y, et al. Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J Immunol. 2010;185(4):2240\u201352.","journal-title":"J Immunol"},{"issue":"2","key":"2289_CR110","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/1352458517695892","volume":"24","author":"E Giacomini","year":"2018","unstructured":"Giacomini E, Rizzo F, Etna MP, et al. Thymosin-alpha1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients. Mult Scler. 2018;24(2):127\u201339.","journal-title":"Mult Scler"},{"issue":"2","key":"2289_CR111","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clim.2014.02.001","volume":"151","author":"Y Miyazaki","year":"2014","unstructured":"Miyazaki Y, Niino M, Fukazawa T, et al. Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations. Clin Immunol. 2014;151(2):127\u201335.","journal-title":"Clin Immunol"},{"issue":"7423","key":"2289_CR112","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","volume":"491","author":"A Yoshizaki","year":"2012","unstructured":"Yoshizaki A, Miyagaki T, Dilillo DJ, et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature. 2012;491(7423):264\u20138.","journal-title":"Nature"},{"issue":"5","key":"2289_CR113","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/eji.201343683","volume":"44","author":"S Ries","year":"2014","unstructured":"Ries S, Hilgenberg E, Lampropoulou V, et al. B-type suppression: a role played by \u201cregulatory B cells\u201d or \u201cregulatory plasma cells\u201d? Eur J Immunol. 2014;44(5):1251\u20137.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2289_CR114","doi-asserted-by":"publisher","first-page":"e0146971","DOI":"10.1371\/journal.pone.0146971","volume":"11","author":"CH Nielsen","year":"2016","unstructured":"Nielsen CH, Bornsen L, Sellebjerg F, et al. Myelin basic protein-induced production of tumor necrosis factor-alpha and interleukin-6, and presentation of the immunodominant peptide MBP85-99 by B cells from patients with relapsing-remitting multiple sclerosis. PLoS ONE. 2016;11(1):e0146971.","journal-title":"PLoS ONE"},{"issue":"9","key":"2289_CR115","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805\u201315.","journal-title":"Lancet Neurol"},{"issue":"4\u20135","key":"2289_CR116","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.autrev.2014.01.034","volume":"13","author":"T Drori","year":"2014","unstructured":"Drori T, Chapman J. Diagnosis and classification of neuromyelitis optica (Devic\u2019s syndrome). Autoimmun Rev. 2014;13(4\u20135):531\u20133.","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2289_CR117","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1073\/pnas.1017385108","volume":"108","author":"N Chihara","year":"2011","unstructured":"Chihara N, Aranami T, Sato W, et al. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci USA. 2011;108(9):3701\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2289_CR118","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol. 2010;6(7):383\u201392.","journal-title":"Nat Rev Neurol"},{"issue":"9451","key":"2289_CR119","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106\u201312.","journal-title":"Lancet"},{"key":"2289_CR120","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/NDT.S147360","volume":"13","author":"J Han","year":"2017","unstructured":"Han J, Yang MG, Zhu J, et al. Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations. Neuropsychiatr Dis Treat. 2017;13:2653\u201360.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"2289_CR121","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s10875-012-9709-9","volume":"32","author":"H Wang","year":"2012","unstructured":"Wang H, Wang K, Zhong X, et al. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol. 2012;32(5):1007\u201311.","journal-title":"J Clin Immunol"},{"issue":"6","key":"2289_CR122","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/brain\/awz106","volume":"142","author":"E Cotzomi","year":"2019","unstructured":"Cotzomi E, Stathopoulos P, Lee CS, et al. Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production. Brain. 2019;142(6):1598\u2013615.","journal-title":"Brain"},{"key":"2289_CR123","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2015.03.016","volume":"282","author":"C Quan","year":"2015","unstructured":"Quan C, Zhangbao J, Lu J, et al. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy. J Neuroimmunol. 2015;282:45\u201353.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2289_CR124","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s00281-014-0424-x","volume":"36","author":"M Krumbholz","year":"2014","unstructured":"Krumbholz M, Meinl E. B cells in MS and NMO: pathogenesis and therapy. Semin Immunopathol. 2014;36(3):339\u201350.","journal-title":"Semin Immunopathol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-020-02289-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:23:03Z","timestamp":1615940583000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02289-w","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"14 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interests regarding the publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}